No Data
No Data
No Data
No Data
No Data
AI drug developer “British Silicon Intelligence”, or listed in Hong Kong. The IPO team includes CICC and Morgan Stanley
Foreign news quoted people familiar with the matter as saying that Insilico Medicine (Insilico Medicine), an AI drug developer, plans to go public in Hong Kong and has appointed CICC and Morgan Stanley to carry out related work. Inco Intelligence expects to raise about 200 million US dollars in capital.
瑞恩資本RyanbenCapitalApr 8, 2023 11:29
Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement
SEATTLE, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Intrinsic Medicine, Inc. (Intrinsic), a therapeutics company leveraging human milk biology to transform Gut-Brain Axis (GBA) and inflammatory disorders, and Phoenix Biotech
GlobeNewswireDec 7, 2022 10:22
Phoenix Biotech to Take Intrinsic Medicine Public in SPAC Deal
11:39 AM EDT, 10/31/2022 (MT Newswires) -- Phoenix Biotech Acquisition (PBAX), a blank-check company, and Intrinsic Medicine said Monday they have agreed to merge in a deal that would take Intrinsic p
MT NewswiresOct 31, 2022 23:40
Press Release: Intrinsic Medicine and Phoenix -2-
Intrinsic Medicine, Inc. is a preclinical-stage therapeutics company leveraging synthetic biology-manufactured human milk oligosaccharides (HMOs), as new medicines to treat large patient populations u
Dow JonesOct 31, 2022 20:08
Intrinsic Medicine Files to Withdraw Planned IPO
By Stephen Nakrosis Intrinsic Medicine Inc. filed a request with the U.S. Securities and Exchange Commission to withdraw its planned initial public offering. In the filing, the company said it has d
Dow JonesJul 26, 2022 05:42
Intrinsic Medicine Withdraws IPO Filing
Intrinsic Medicine Withdraws IPO Filing
Dow JonesJul 26, 2022 05:23
No Data
No Data